Overview

A Study to Evaluate Pharmacokinetic Parameters and Safety of Eliglustat Absorption Through the Mouth

Status:
Completed
Trial end date:
2014-09-21
Target enrollment:
Participant gender:
Summary
A study to assess the absorption of eliglustat through the mouth in healthy subjects and the safety of any systemic exposure resulting from oral surface absorption of eliglustat in healthy subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Sanofi
Treatments:
Eliglustat